Dr. Chantelle Thomas
speaker
1,116 appearances
2 recordings
1 series
first heard Jul 2026
last heard 30 Jul
Dr. Chantelle Thomas’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 2 in all, peaking in Jul 2026 with 2.
Appearances
Another way to think about that is they externalize the locus of control.
So this drug will do the thing that fixes me.
And as I mentioned um before, these are interaction effects with a compound and someone's own personal lived experience and history.
And the way you approach them matters greatly.
That's definitely my bias.
Okay.
I would say that not everybody feels that way.
I think they create and facilitate opportunities when under the optimal conditions allow people to reach deeper and explore parts of their experience and their consciousness that would otherwise be very difficult to access.
Not unless you have a very good dealer.
So the compound that's being used in these clinical tries is trials is highly regulated.
Uh and very often on the streets when you're buying a compound um or drug, it's being mixed with other drugs.
So it's very hard to know the purity
the
One challenge that I've run into with this many times is it feels like when you have a conversation about psychedelics, you almost need two parts.
I know that we talked about the idea of reviewing different compounds, but
The challenge is that for people who are quite skeptical, you want to talk about all the opportunities and the potential benefits and the research.
And then what often happens is people go, Oh my gosh, these drugs are miracle drugs.
I can't believe they exist.
How can I have this opportunity to go do them right now?
The second part of the conversation should always involve more complexity, nuance, discernment, and a discussion about what it looks like when things go really badly with these compounds.
Showing 641–660 of 1,116 · page 33 of 56
← Previous
Next →